SCHEMBL21273152

SCHEMBL21273152

COc1ccc(-n2c(Cl)cc3c(Cl)ncnc32)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 3/20 0.41
BRD9 Q9H8M2 3/20 0.41
CYP2C9 P11712 1/20 0.41
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
TNF P01375 1/20 0.39
LITAF Q99732 1/20 0.39
AURKA O14965 1/20 0.38
MAPT P10636 5/20 0.38
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PIP4K2A P48426 3/20 0.37
LMNA P02545 3/20 0.37
TP53 P04637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PIK3CG P48736 1/20 0.36
PIP4K2C Q8TBX8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21272835 0.88 USP7 (0.47) ENPP1AURKAPIK3CGUSP7
SCHEMBL20351796 0.78 PIP4K2A (0.53) ENPP1GAAAURKAMAPTALDH1A1
SCHEMBL21273155 0.77 CYP2C9 (0.46) BRD9CYP2C9GAAMAPK1TNF
SCHEMBL21272908 0.76 RXRA (0.36) MAPTTP53USP7
SCHEMBL11829935 0.73 PI4KA (0.48) PIP4K2ALMNATP53
SCHEMBL21273198 0.72 USP7 (0.42) CYP2C9GAAMAPTALDH1A1MEN1
SCHEMBL23754587 0.72 MAOA (0.35) PIK3CG
SCHEMBL23754582 0.72 PTGS1 (0.43) AURKAMAPTLMNATP53PIK3CG
SCHEMBL23754620 0.72 PTGS1 (0.37) MAPTALDH1A1LMNATP53KDM4E
SCHEMBL21273222 0.71 DGAT1 (0.43) GAAMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 ENPP1 1583/4885BRD9 710/4885CYP2C9 4240/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 ENPP1 1583/4885BRD9 710/4885CYP2C9 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.